Search Results - "Yu, Shawn S"

Effects of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial by Leese, Philip T., Hubbard, Richard C., Karim, Aziz, Isakson, Peter C., Yu, Shawn S., Geis, G. Steven

“…Conventional nonsteroidal anti‐inflammatory drugs (NSAIDs) nonspecifically inhibit cyclooxygenase‐1 (COX‐1), an enzyme critical to normal platelet function,…”
Get full text

Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis: A Randomized Controlled Trial by Simon, Lee S, Weaver, Arthur L, Graham, David Y, Kivitz, Alan J, Lipsky, Peter E, Hubbard, Richard C, Isakson, Peter C, Verburg, Kenneth M, Yu, Shawn S, Zhao, William W, Geis, G. Steven

“…CONTEXT In vitro studies have shown that celecoxib inhibits cyclooxygenase 2 (COX-2) but not COX-1, suggesting that this drug may have anti-inflammatory and…”
Get full text

Mo1049 Physician and Patient Knowledge of and Adherence to Dosing Directions for Proton Pump Inhibitors in the Treatment of GERD by Solem, Caitlyn T, Mody, Reema, Stephens, Jennifer M, Macahilig, Cynthia, Yu, Shawn S, Gao, Xin

Get full text

Treatment of Osteoarthritis with a Once-Daily Dosing Regimen of Celecoxib: A Randomized, Controlled Trial by Williams, Gary W, Ettlinger, Robert E, Ruderman, Eric M, Hubbard, Richard C, Lonien, Mary E, Yu, Shawn S, Zhao, William, Geis, Steven G

“…A previous study has shown celecoxib 100 mg b.i.d. to be comparably effective to naproxen 500 mg b.i.d. in treating osteoarthritis (OA). The primary objective…”
Get full text

Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee by Williams, Gary W., Hubbard, Richard C., Yu, Shawn S., Zhao, William, Steven Geis, G.

“…Objective: The purpose of this study was to compare the efficacy and tolerability of a celecoxib 200 mg QD regimen with a 100 mg BID regimen in patients with…”
Get full text

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial by Bensen, W G, Fiechtner, J J, McMillen, J I, Zhao, W W, Yu, S S, Woods, E M, Hubbard, R C, Isakson, P C, Verburg, K M, Geis, G S

“…To compare the efficacy and safety of celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, with those of naproxen, a nonsteroidal anti-inflammatory drug (NSAID),…”
Get more information

Evaluation of the Functional Status Aspects of Health-Related Quality of Life of Patients with Osteoarthritis Treated with Celecoxib by Zhao, Sean Z., McMillen, James I., Markenson, Joseph A., Dedhiya, Seema D., Zhao, William W., Osterhaus, Jane T., Yu, Shawn S.

“…Study Objective. To evaluate the functional status of patients with signs and symptoms of osteoarthritis of the knee after treatment with celecoxib compared…”
Get full text

Evaluation of health‐related quality of life of rheumatoid arthritis patients treated with celecoxib by Zhao, Sean Z., Fiechtner, Justus I., Tindall, Elizabeth A., Dedhiya, Seema D., Zhao, William W., Osterhaus, Jane T., Yu, Shawn S.

“…Objective To study the functional status and health‐related quality of life (HRQOL) of patients with rheumatoid arthritis (RA) after treatment with celecoxib,…”
Get full text